Biochemical markers of thrombotic complications in the acute period of ischemic stroke

Biochemical markers of thrombotic complications in the acute period of ischemic stroke

Aim. To study the profile of biochemical markers of the hemostasis system, to clarify their role and relationships in the pathogenesis of the development of thrombotic complications (TC) of ischemic stroke (IS) and the associated assessment of the possibilities of their diagnostic application. Ma...

Full description

Bibliographic Details
Main Authors:	Anatoly G. Kochetov, Olga V. Lyang, Irina A. Zhirova, Oleg O. Ivoylov
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2022-08-01
Series:	Терапевтический архив
Subjects:	thrombotic complications ischemic stroke biomarker fibronectin plasminogen activator and inhibitor complex
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/109715/83953

Similar Items

Proinflammatory laboratory predictors of pneumonia in ischemic stroke patients: prospective study
by: Anatoly G. Kochetov, et al.
Published: (2022-05-01)

Two ischemic stroke events within 48 h: a case report of an unusual presentation of thrombotic thrombocytopenic purpura
by: Melika Jameie, et al.
Published: (2023-01-01)

Development and reliability of the histological THROMBEX-classification rule for thrombotic emboli of acute ischemic stroke patients
by: Julika Ribbat-Idel, et al.
Published: (2021-09-01)

Comparative analysis of the hemostasis system of cancer patients with thrombotic complications
by: P. Ya. Bodnar
Published: (2021-07-01)

Heart - type fatty acid binding protein in prognosis of ischemic stroke at the hospital stage
by: O V Lyang, et al.
Published: (2019-12-01)

HORMONE REPLACEMENT THERAPY AND PREVENTION OF THROMBOTIC COMPLICATIONS
by: A. V. Vorob'ev, et al.
Published: (2016-06-01)

Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
by: Gaber El-Saber Batiha, et al.
Published: (2022-09-01)

The Effect of Homocysteine Levels on Thrombolytic Treatment in Acute Ischemic Stroke
by: Ezgi Yılmaz, et al.
Published: (2022-12-01)

Thromboembolic complications following tissue plasminogen activator therapy in patients of acute ischemic stroke - Case report and possibility for detection of cardiac thrombi
by: Yamaguchi Junko, et al.
Published: (2018-11-01)

Ischemic stroke with unknown onset of symptoms: current scenario and perspectives for the future
by: Rônney Pinto Lopes, et al.
Published: (2022-12-01)

Severe Hyperkalemia Masquerading as Acute Ischemic Stroke: A Case Report
by: Zahra Bahrami, et al.
Published: (2022-11-01)

Evaluation of Patients with Ischemic Stroke Receiving iv t-PA in the Emergency Department
by: Omer Salt, et al.
Published: (2018-06-01)

Perioperative prothrombin complex concentrate and fibrinogen administration are associated with thrombotic complications after liver transplant
by: Sarah Dehne, et al.
Published: (2022-11-01)

A temible complication of ischemic stroke: pulmonary embolism
by: Linda Iurato, et al.
Published: (2015-12-01)

The first reported case of acute ischemic stroke treated with tissue plasminogen activator at Mansoura University, Egypt
by: Ahmed Farouk Donia, et al.
Published: (2017-12-01)

Acute Ischemic Stroke in Term Pregnancy Treated with Recombinant Tissue Plasminogen Activator
by: Sanjith Aaron, et al.
Published: (2020-12-01)

Application of anti-thrombotic drugs and the safety of prostate biopsy
by: ZUO Yu-zhi, YAN Wei-gang
Published: (2022-05-01)

Thrombotic diseases and conditions – diagnosis and monitoring of anticoagulant therapy
by: A. L. Melkumyan, et al.
Published: (2021-01-01)

Intravenous thrombolysis with rt-plasminogen activator in patients with acute ischemic stroke: clinical experience from two Egyptian centers
by: Nabil Mohamed, et al.
Published: (2020-01-01)

Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke
by: Xu Tong, et al.
Published: (2020-10-01)

Intravenous thrombolysis in ischemic stroke: clinical predictors of efficacy and safety
by: Maksim A. Domashenko, et al.
Published: (2019-03-01)

Lipoprotein (a) and other Lipid Profile in Patients with Thrombotic Stroke: Is it a Reliable Marker?
by: Shashidhar K Nagaraj, et al.
Published: (2011-01-01)

To Treat or Not to Treat: Low‐Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours
by: Wayneho Kam, et al.
Published: (2022-10-01)

Intravenous Thrombolysis Prior to Mechanical Thrombectomy in Acute Ischemic Stroke: Silver Bullet or Useless Bystander?
by: Federico Di Maria, et al.
Published: (2018-09-01)

Mycoplasma synoviae LP78 is a fibronectin/plasminogen binding protein, putative adhesion, and potential diagnostic antigen
by: Shuizhong Han, et al.
Published: (2024-01-01)

A multifunctional enolase mediates cytoadhesion and interaction with host plasminogen and fibronectin in Mycoplasma hyorhinis
by: Jia Wang, et al.
Published: (2022-03-01)

Tissue plasminogen activator and patients with acute ischemic stroke: The litigation landscape
by: Latha Ganti, et al.
Published: (2022-02-01)

A case of congenital afibrinogenemia with multiple thrombotic and hemorrhagic disorders
by: Lijian Wei, et al.
Published: (2022-10-01)

COVID‐19‐induced thrombotic microangiopathy: A great mimicker of thrombotic thrombocytopenic purpura (TTP)
by: Brian Warnecke, et al.
Published: (2023-01-01)

Effect of isoflurane post-treatment on tPA-exaggerated brain injury in a rat ischemic stroke model
by: Eun Jung Kim, et al.
Published: (2015-06-01)

Role of the gut microbiota in complications after ischemic stroke
by: Jinwei Zhang, et al.
Published: (2024-04-01)

THROMBOTIC MICROANGIOPATHY IN THE PATHOGENESIS OF OBSTETRIC COMPLICATIONS
by: S. V. Akinshina, et al.
Published: (2016-06-01)

In Silico Study of Different Thrombolytic Agents for Fibrinolysis in Acute Ischemic Stroke
by: Yilin Yang, et al.
Published: (2023-02-01)

Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke
by: Hongyin Ma, et al.
Published: (2021-01-01)

Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke
by: Tao Peng, et al.
Published: (2023-08-01)

Endovascular thrombectomy for the treatment of ischemic stroke: An updated meta-analysis for a randomized controlled trial
by: Jia Feng, et al.
Published: (2021-09-01)

The course of the acute period of ischemic stroke after inravenous thrombolysis
by: M. A. Domashenko, et al.
Published: (2017-02-01)

The Ischemic Penumbra: Still the Target for Acute Stroke Therapies
by: Argye E. Hillis
Published: (2015-04-01)

Role of the studyof urinary molecular mediators of immune inflammationand renal fibrosis in chronic glomerulonephritis
by: L V Kozlovskaya, et al.
Published: (2004-09-01)

Hereditary Thrombotic Thrombocytopenic Purpura
by: Sanober Nusrat, et al.
Published: (2023-10-01)